Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humalog Mix 75/25 vs Glargine + Humalog in Type 2 Diabetes
NCT01175824Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2011
- Primary completion
- Nov 2012
- Countries
- 8
01
Overview
Phase 4, randomised, open-label trial of insulin lispro mix25 in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Apr 2011; status: completed.
02
Drugs
insulin lispro mix25
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01175824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175824.